Older cancer survivor population to increase substantially

October 6, 2011, American Association for Cancer Research

Over the next decade, the population of cancer survivors over 65 years of age will increase by approximately 42 percent.

"We can expect a dramatic increase in the number of older adults who are diagnosed with or carry a history of cancer," said Julia Rowland, Ph.D., director of the Office of in the Division of and Population Sciences at the (NCI). "Cancer is largely a disease of aging, so we're seeing yet another effect of the and we need to prepare for this increase."

Rowland's report is part of the special focus on cancer survivorship, published in the October issue of , Biomarkers & Prevention, a journal of the American Association for Cancer Research. Rowland and colleagues analyzed data from the NCI Surveillance, Epidemiology and End Results Program. This report on cancer survivorship statistics will be updated and published on an annual basis.

They found that in 1971, the year the National Cancer Act was signed, the survivor population was approximately 3 million, which increased to nearly 12 million in 2008, the last year data are available.

In 2008, 60 percent of the cancer survivors were at least 65 years old. The NCI projects this number will increase to 63 percent by 2020.

The most common diagnosis among cancer survivors includes female breast cancer (22 percent), prostate cancer (20 percent) and colorectal cancer (9 percent). Researchers attribute this high survival to improved detection and screening. Lung cancer, which is by far the most diagnosed cancer in men and women, is much lower in the survivor population at just 3 percent.

Rowland said the health care community needs to prepare for the coming wave of who will present some unique challenges. As a population, the number of oncologists and geriatric specialists is decreasing just as the need for these specialists is increasing.

"We may be fortunate in that the aging population is healthier than in previous generations, and new technologies could allow for better communication and follow-up," she said.

Explore further: Sexual orientation affects cancer survivorship

Related Stories

Sexual orientation affects cancer survivorship

May 9, 2011
Gay men have a higher prevalence of cancer compared with heterosexual men, and lesbian and bisexual female cancer survivors report lower levels of health than heterosexual female cancer survivors. Those are the conclusions ...

Study: Doctors differ in how best to care for America's 12 million cancer survivors

July 25, 2011
There are major differences between oncologists and primary care physicians regarding knowledge, attitudes, and practices required to care for American's 12 million cancer survivors. That is the key finding of the first ...

Depression affected preventive health screening among Latina breast cancer survivors

September 19, 2011
Depression, in addition to other barriers, may prevent Latina breast cancer survivors from undergoing preventive health screening for colorectal and ovarian cancer, according to data presented at the Fourth AACR Conference ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.